Samrat Pharmachem Stock Screener | Share Price & Fundamental Analysis
SAMRATPH
Pharmaceuticals
Share Price BSE
₹215.80
▲
14.25 (7.07%)
Track Samrat Pharmachem share price live with TickJournal's free stock screener.
Analyze Samrat Pharmachem share price history trends and compare 52-week high low
levels.
Calculate SAMRATPH stock fair value using fundamental analysis and view live share price charts.
Determine Samrat Pharmachem share intrinsic value and compare it with current SAMRATPH share price.
Record your Samrat Pharmachem trades in TickJournal's free trading journal and track your portfolio performance.
Samrat Pharmachem Market Cap
₹72.33 Cr.
SAMRATPH P/E Ratio (TTM)
15.00
EPS (TTM)
₹23.02
Dividend Yield
0.43%
Debt to Equity
0.13
SAMRATPH 52 Week High
₹410.15
Samrat Pharmachem 52 Week Low
₹200.50
Operating Margin
2.00%
Profit Margin
0.69%
SAMRATPH Revenue (TTM)
₹290.00
EBITDA
₹5.00
Net Income
₹2.00
Total Assets
₹122.00
Total Equity
₹72.00
Samrat Pharmachem Share Price History - Stock Screener Chart
Screen SAMRATPH historical share price movements with interactive charts. Analyze price trends and patterns.
Samrat Pharmachem Company Profile - Fundamental Screener
Screen Samrat Pharmachem company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for SAMRATPH shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE103E01016
Samrat Pharmachem Balance Sheet Screener
Screen SAMRATPH balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 122 | 122 | 117 | 85 | 57 | 58 | 40 | 41 | 36 | 36 |
| Current Assets | 103 | 103 | 99 | 71 | 47 | 50 | 33 | 33 | 28 | 28 |
| Fixed Assets | 11 | 11 | 11 | 10 | 9 | 7 | 7 | 7 | 7 | 7 |
| Liabilities | ||||||||||
| Total Liabilities | 122 | 122 | 117 | 85 | 57 | 58 | 40 | 41 | 36 | 36 |
| Current Liabilities | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 2 | 2 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 72 | 65 | 63 | 47 | 30 | 24 | 20 | 19 | 15 | 14 |
| Share Capital | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Reserves & Surplus | 69 | 62 | 60 | 44 | 27 | 21 | 17 | 15 | 12 | 11 |
Samrat Pharmachem Income Statement Screener - Profit & Revenue Analysis
Screen Samrat Pharmachem income statement and profit fundamentals.
Analyze SAMRATPH quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Samrat Pharmachem share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 290 | 287 | 283 | 311 | 222 | 180 | 138 | 112 | 93 | 71 | 62 | 48 |
| Expenses | 285 | 276 | 279 | 287 | 198 | 170 | 131 | 108 | 87 | 67 | 61 | 46 |
| EBITDA | 5 | 11 | 4 | 24 | 25 | 9 | 7 | 4 | 6 | 4 | 1 | 2 |
| Operating Profit % | 2.00% | 4.00% | 1.00% | 8.00% | 11.00% | 5.00% | 5.00% | 3.00% | 6.00% | 5.00% | 2.00% | 2.00% |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit Before Tax | 3 | 10 | 3 | 23 | 24 | 7 | 6 | 2 | 5 | 3 | 0 | 1 |
| Tax | 1 | 3 | 0 | 6 | 6 | 2 | 2 | 1 | 2 | 1 | 0 | 0 |
| Net Profit | 2 | 7 | 2 | 17 | 17 | 5 | 4 | 2 | 3 | 2 | 0 | 0 |
| EPS | 5.10 | 23.02 | 7.00 | 53.83 | 55.62 | 17.26 | 13.71 | 4.97 | 10.41 | 5.68 | 0.97 | 1.02 |
Samrat Pharmachem Cash Flow Screener - Liquidity Fundamentals
Screen SAMRATPH cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -10 | 9 | -9 | 18 | 5 | -1 | 2 | 0 | -3 | 0 |
| Investing Activities | 0 | 0 | -3 | -1 | -3 | -2 | 2 | -2 | 1 | -2 |
| Financing Activities | 1 | -11 | 10 | -2 | -2 | 2 | -4 | 2 | 1 | 2 |
| Net Cash Flow | -10 | -2 | -3 | 15 | 0 | -1 | 1 | -1 | -1 | 0 |
Samrat Pharmachem Shareholding Pattern Screener
See Samrat Pharmachem shareholding pattern with promoter, FII, and DII holdings.
Check Samrat Pharmachem promoter holding and ownership changes for SAMRATPH on TickJournal.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 49.09% | 49.09% | 49.09% | 48.64% | 48.64% | 48.95% | 49.09% | 48.64% |
| FII Holding | 3.24% | 0.00% | 3.24% | 3.24% | 3.24% | 3.24% | 3.24% | 0.00% |
| DII Holding | 0.00% | 3.24% | 0.00% | 0.22% | 0.22% | 0.22% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 41.58% | 41.64% | 41.73% | 41.69% | 40.79% | 41.34% | 41.95% | 38.48% |
| Other Holding | 6.09% | 6.04% | 5.95% | 6.22% | 7.11% | 6.25% | 5.72% | 12.88% |
| Shareholder Count | 6,785 | 6,752 | 6,699 | 7,478 | 7,169 | 6,984 | 6,844 | 8,039 |
Samrat Pharmachem Share Dividend Screener - Share Yield Analysis
Check Samrat Pharmachem dividend history with payout and yield data.
View Samrat Pharmachem dividend details including ex-dates and amounts for SAMRATPH stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2025-March | ₹1.00 | 0.43% |
| 2024-March | ₹1.00 | 0.32% |
| 2023-March | ₹1.00 | 0.30% |
| 2022-March | ₹1.00 | 0.28% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
| 2016-March | ₹0.00 | 0.00% |
Samrat Pharmachem Stock Index Membership
See which indices include Samrat Pharmachem stock.
Check SAMRATPH index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Samrat Pharmachem Market Events Screener - Corporate Actions
Get Samrat Pharmachem corporate actions including splits, bonuses, and buybacks.
Check Samrat Pharmachem stock events that may affect SAMRATPH share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Dividend | ₹ 1.00 /share | -18.51% | ||
| Dividend | ₹ 1.00 /share | -18.65% | ||
| Dividend | ₹ 1.00 /share | 76.20% | ||
| Annual General Meeting | NA | 48.09% | ||
| Dividend | ₹ 1.00 /share | 162.00% | ||
| Annual General Meeting | NA | -20.77% | ||
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | -14.06% |
| 2025-08-13 | 2025-08-13 | Quarterly Result Announcement | NA | 0.67% |
| 2025-05-30 | 2025-05-30 | Quarterly Result Announcement | NA | 24.89% |
| 2025-02-14 | 2025-02-14 | Quarterly Result Announcement | NA | -9.48% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -16.31% |
Samrat Pharmachem Competitors Screener - Peer Comparison
Screen SAMRATPH competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 424,850 | 40.53 | 54,729 | 9.71% | 10,980 | 49.55 |
| Divis Laboratories | 172,395 | 69.57 | 9,712 | 18.67% | 2,191 | 56.33 |
| Torrent Pharmaceuticals | 129,005 | 60.33 | 11,539 | 6.99% | 1,911 | 61.47 |
| Cipla | 122,213 | 22.48 | 28,410 | 7.12% | 5,291 | 49.47 |
| Dr Reddys Laboratories | 107,073 | 18.68 | 33,741 | 16.73% | 5,725 | 60.05 |
| Lupin | 96,814 | 22.34 | 22,910 | 13.74% | 3,306 | 65.28 |
| Zydus Life Science | 92,800 | 18.37 | 23,511 | 18.55% | 4,615 | 40.07 |
| Mankind Pharma | 92,086 | 50.91 | 12,744 | 20.90% | 2,007 | 45.53 |
| Aurobindo Pharma | 71,340 | 20.79 | 32,346 | 9.43% | 3,484 | 59.88 |
| Alkem Laboratories | 67,494 | 27.88 | 13,458 | 3.70% | 2,216 | 49.80 |
Samrat Pharmachem Company Announcements - News Screener
Screen SAMRATPH latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2025-12-02 | Announcement under Regulation 30 (LODR)-Credit Rating | View |
| 2025-11-20 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-14 | Un-Audited Financial Results For The Quarter And Half Year Ended 30Th September 2025 | View |
| 2025-11-14 | Board Meeting Outcome for Outcome Of Board Meeting Held Today | View |
| 2025-10-10 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-09-27 | Corporate Action-Board approves Dividend | View |
| 2025-09-27 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-09-26 | Board Meeting Intimation for Un-Audited Financial Results For The Quarter Ended September 30 2025 | View |
| 2025-09-26 | Closure of Trading Window | View |
| 2025-09-25 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-09-04 | Reg. 34 (1) Annual Report. | View |
| 2025-09-04 | Book Closure: Friday September 19 2025 To Thursday September 25 2025 (Both Days Inclusive) | View |
| 2025-09-04 | Record Date - Thursday September 18 2025 | View |
| 2025-09-04 | Notice Of 33Rd Annual General Meeting Of Samrat Pharmachem Limited On Thursday September 25 2025 | View |
| 2025-08-19 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-08-13 | Un-Audited Financial Results For The Quarter Ended June 30 2025 | View |
| 2025-08-13 | Board Meeting Outcome for Outcome Of Board Meeting | View |
| 2025-07-25 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2025-07-18 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-07-16 | Announcement under Regulation 30 (LODR)-Change in Management | View |